Enhancement of the prolactin response to d-fenfluramine in drug-naive schizophrenic patients

British Journal of Psychiatry

Volumn 168, Issue JAN., 1996, Pages 57-60

  Abel, Kathryn M ^a   O'Keane, Veronica ^b   Murray, Robin M ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DEXFENFLURAMINE; PROLACTIN;

ADULT; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; DEPRESSION; DRUG EFFECT; FEMALE; GUILT; HUMAN; MALE; PROLACTIN BLOOD LEVEL; PROLACTIN RELEASE; SCHIZOPHRENIA;

EID: 0029897502     PISSN: 00071250     EISSN: None     Source Type: Journal    
DOI: 10.1192/bjp.168.1.57     Document Type: Article

References (13)

1. AMERICAN PSYCHIATRIC PRESS (1987) Diagnostic and Statistical Manual of Mental Disorders (3rd edn, revised) (DSM-III-R). Washington, DC: APA.
2. BLEICH, A., BROWN, S-L., KAHN, R., et al (1988) The role of serotonin in schizophrenia. Schizophrenia Bulletin, 14, 297-315.
3. CEULEMANS, D. L. S., GELDERS, Y. G., HOPPENBROUWERS, M-L. J. A., et al (1985) Effect of serotonin antagonism in schizophrenia: A pilot study with setoperone. Psychopharmacology, 85, 329-332.
4. COWEN, P. J., GADHRI, H., GOSDEN, B., et al (1985) Responses of prolactin and growth hormone to L-tryptophan infusion. Effects in normal subjects and schizophrenic patients receiving neuroleptics. Psychopharmacology, 86, 164-169.
5. CSERNANSKY, J. G., WRONA, C. T., BARDGETT, M. E., et al (1993) Subcortical dopamine and serotonin turnover during acute and subchronic administration of typical and atypical neuroleptics. Psychopharmacology, 110, 145-151.
6. 2/1c antagonist, and negative symptoms in schizophrenia: A placebo-controlled double-blind trial. British Journal of Psychiatry, 163, 451-455.
7. FEENEY, S., GOODALL, E. & SILVERSTONE, T. (1993) The prolactin response to d- and l- fenfluramine and to d-amphetamine in human subjects. International Clinical Psychopharmacology, 8, 49-54.
8. GOODALL, E. M., COWEN, P. J., FRANKLIN, M., et al (1993) Ritanserin attenuates anorectic, endocrine and thermic response to d-fenfluramine in human volunteers. Psychopharmacology, 112, 461-466.
9. IQBAL, N. & VAN PRAAG, H. M. (1995) The role of serotonin in schizophrenia. In Advances in the Neurobiology of Schizophrenia (ed. J. A. Den Boer). New York: Wiley.
10. KRYSTAL, J. H., SEIBYL, J. P., PRICE, L., et al (1993) m-Chlorophenyl-piperazine effects in neuroleptic-free schizophrenic patients. Archives of General Psychiatry, 50, 624-635.
11. O'KEANE, V. & DINAN, T. G. (1991) Prolactin and cortisol responses to d-Fenfluramine in major depression: Evidence for diminished responsibility of central serotonergic function. American Journal of Psychiatry, 148, 1009-1015.
12. 2 receptors in schizophrenia and antipsychotic activity. International Clinical Psychopharmacololgy, 8(suppl.2), 25-32.
13. 2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition. Psychopharmacology, 98, 45-50.